Finance

Beta
Lists
DERM:NASDAQ
Journey Medical Corp
$7.08
+4.27%
(+0.29) 1D
$7.22
+1.98% (+0.14)
Pre-market
Closed: Jun 30, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DERM...
Open
$6.71
High
$7.15
Low
$6.57
Mkt. cap
152.46M
Avg. vol.
330.10K
Volume
0.00
52-wk high
$9.55
52-wk low
$4.31
EPS
-$0.38
Beta
1.09
Shares outstanding
21.54M
No. of employees
58
Open
$6.71
High
$7.15
Low
$6.57
Mkt. cap
152.46M
Avg. vol.
330.10K
Volume
0.00
52-wk high
$9.55
52-wk low
$4.31
EPS
-$0.38
Beta
1.09
Shares outstanding
21.54M
No. of employees
58
News stories
From sources across the web
About Journey Medical Corp
CEO-
Employees58
Founded2014
HeadquartersScottsdale, Arizona, United States
SectorPharmaceutical industry
Websitejourneymedicalcorp.com
Analyst ratings
Based on 3 analysts giving stock ratings to DERM in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for DERM in the last 3 months.
Highest
Current $7.08
$16.00 (+125.99%)
Average
$14.00 (+97.74%)
Lowest
$13.00 (+83.62%)
Analyst
Recommendation
Action
Price target
Projected
Date
Scott Henry
Alliance Global Partners
Buy
Reiterated
$16.00
+126%
05/14/2026
Thomas Flaten
Lake Street
Buy
Maintained
$13.00
+83.6%
05/14/2026
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
$13.00
+83.6%
05/14/2026
Unknown Analyst
Alliance Global Partners
Buy
Reiterated
$16.00
+126%
03/26/2026
Mayank Mamtani
B. Riley Securities
Buy
Reiterated
$12.00
+69.5%
03/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
15.01M
17.63M
16.08M
15.96M
Cost of goods sold
4.94M
5.76M
5.44M
6.22M
Cost of revenue
4.94M
5.76M
5.44M
6.22M
Research and development expenses
-
287.00K
154.00K
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.88M
12.05M
9.86M
10.11M
Operating expense
12.95M
13.40M
11.08M
11.24M
Total operating expenses
17.88M
19.16M
16.52M
17.45M
Operating income
-2.88M
-1.53M
-443.00K
-1.49M
Other non operating income
-
-
-
-
EBT including unusual items
-3.74M
-2.32M
-1.25M
-2.23M
EBT excluding unusual items
-3.74M
-2.32M
-1.25M
-2.23M
Income tax expense
60.00K
-
-
-
Effective tax rate
-1.61%
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.80M
-2.32M
-1.25M
-2.23M
Net profit margin
-25.29%
-13.13%
-7.76%
-13.97%
Earnings per share
-
-
-
-
Interest and investment income
138.00K
154.00K
148.00K
157.00K
Interest expense
-937.00K
-937.00K
-933.00K
-892.00K
Net interest expenses
-799.00K
-783.00K
-785.00K
-735.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.81M
-465.00K
622.00K
-366.00K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer